PHARMACORP RX INC. (“PharmaCorp ” or the “Corporation ”) (TSXV:PCRX) is pleased to announce that it has filed its Final Short Form Base Shelf Prospectus dated October 14, 2025 (the “Prospectus ”) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results